Sanofi offers to remedy EU’s antitrust concerns over flu vaccine (update*)
French pharma company Sanofi will make public declarations for up to four years to correct the potentially anticompetitive impact of claims about a rival flu treatment. The move is designed to...To view the full article, register now.
Already a subscriber? Click here to view full article